Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
QuidelOrtho: Margins Normalizing Lower But Stable
01:09am, Monday, 18'th Dec 2023
QuidelOrtho's Labs Segment has increased greatly in size with the merger and has potential for growth with plans for multiple product launches and a strategic partnership in China. The company's free
QuidelOrtho (QDEL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
09:02pm, Wednesday, 01'st Nov 2023
The headline numbers for QuidelOrtho (QDEL) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street
QuidelOrtho: Thoughts After A Tough Time
06:56am, Wednesday, 27'th Sep 2023
QuidelOrtho benefited from the pandemic, using proceeds to buy back shares and announce a large deal. The acquisition of Ortho Clinical Diagnostics added diversification but also increased leverage. Q
3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio
02:17pm, Wednesday, 13'th Sep 2023
QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock.
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
04:05pm, Monday, 28'th Aug 2023
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical
Down -14% in 4 Weeks, Here's Why You Should You Buy the Dip in QuidelOrtho (QDEL)
11:02am, Thursday, 17'th Aug 2023
QuidelOrtho (QDEL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimat
QuidelOrtho (QDEL) Q2 Earnings Top Estimates, FY23 View Revised
02:27pm, Wednesday, 09'th Aug 2023
Despite solid performances by the Labs segment and Other region, QuidelOrtho (QDEL) reports soft overall top-line results in second-quarter 2023.
QuidelOrtho (QDEL) Reports Q2 Earnings: What Key Metrics Have to Say
10:41pm, Tuesday, 08'th Aug 2023
Although the revenue and EPS for QuidelOrtho (QDEL) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Stre
QuidelOrtho Corporation (QDEL) Q2 2023 Earnings Call Transcript
08:54pm, Tuesday, 08'th Aug 2023
QuidelOrtho Corporation (NASDAQ:QDEL ) Q2 2023 Earnings Call August 8, 2023 5:00 PM ET Company Participants Bryan Brokmeier - Vice President of Investor Relations Douglas C. Bryant - President and Chi
QuidelOrtho (QDEL) Beats Q2 Earnings and Revenue Estimates
07:41pm, Tuesday, 08'th Aug 2023
QuidelOrtho (QDEL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $2.12 per share a year ago.
Wall Street Analysts Believe QuidelOrtho (QDEL) Could Rally 29.87%: Here's is How to Trade
11:36am, Monday, 24'th Jul 2023
The consensus price target hints at a 29.9% upside potential for QuidelOrtho (QDEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estim
Are Investors Undervaluing QuidelOrtho (QDEL) Right Now?
11:21am, Tuesday, 18'th Jul 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
QuidelOrtho: A Tough Call To Make Right Now
02:31am, Thursday, 13'th Jul 2023
QuidelOrtho Corporation's Sofia 2 SARS Antigen+ FIA, the first rapid antigen test that detects Covid-19, was approved by the FDA in March 2023. Despite strong cash flows and a 13% FCF margin, QuidelOr
Reasons to Retain QuidelOrtho (QDEL) Stock in Your Portfolio
01:24pm, Friday, 23'rd Jun 2023
Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its product innovation aiding growth.
QuidelOrtho: 5x Earnings Is Borderline Offensive, Rate Buy At 20x
03:41am, Saturday, 22'nd Apr 2023
QuidelOrtho: 5x Earnings Is Borderline Offensive, Rate Buy At 20x.
